IC
AGIO icon

IEQ Capital’s Agios Pharmaceuticals AGIO Stock Holding History

IEQ Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
+40,404
New +$1.23M 0.01% 935
2025
Q3 		– Sell
-8,086
Closed -$269K – 1835
2025
Q2 		$269K Buy
+8,086
New +$245K ﹤0.01% 1456

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

IEQ Capital's AGIO Position: Q2 2026 in Review

IEQ Capital opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 40,404 shares worth $1.5M. The stake represents 0.01% of the portfolio and ranks #935 among its holdings. This is a return to the name: IEQ Capital previously reported a position in AGIO as recently as Q2 2025.

IEQ Capital first reported a position in AGIO in Q2 2025 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • IEQ Capital held 40,404 shares of Agios Pharmaceuticals worth $1.5M as of Q2 2026.
  • Agios Pharmaceuticals was a new IEQ Capital position in Q2 2026.
  • Agios Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #935 holding.
  • IEQ Capital first reported a position in Agios Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.